📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vitatron

1.1 - Company Overview

Vitatron Logo

Vitatron

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pacemakers—implanted devices that deliver timed electrical discharges to regulate slow or irregular heart rhythms—and the Vitatron 2090 Programmer, used to program and support advanced Vitatron cardiac devices to meet patient-specific needs.

Products and services

  • Vitatron 2090 Programmer: Clinical-grade programmer configuring and supporting advanced Vitatron cardiac devices for patient-specific needs
  • Advanced Vitatron Cardiac Devices: Custom-programmable devices architected to be configured and supported by the 2090 Programmer
  • Pacemakers: Medical-grade implants stimulating heart muscle with timed electrical discharges to regulate slow or irregular rhythms

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vitatron

CardioInsight Logo

CardioInsight

HQ: United States Website
  • Description: Provider of electrocardiographic mapping technology that non-invasively generates 3D images of the heart's electrical activity to help treat arrhythmias and congestive heart failure, and cardiac electrophysiology systems for atrial fibrillation, including noninvasive 3D mapping, pulsed field ablation, cryoballoon, temperature-controlled RF ablation, and cryoablation catheters.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CardioInsight company profile →
Portola Pharmaceuticals Logo

Portola Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics, discovering and developing treatments for acute and chronic cardiovascular and autoimmune/inflammatory diseases, including PRT054021, an oral factor Xa inhibitor for prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Portola Pharmaceuticals company profile →
CV Therapeutics Logo

CV Therapeutics

HQ: United States Website
  • Description: Provider of research-based biopharmaceutical drugs for cardiovascular diseases, particularly angina pectoris, serving the U.S. healthcare industry. The company researches and manufactures cardiovascular drugs and developed Ranexa for chronic angina.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CV Therapeutics company profile →
Enchannel Logo

Enchannel

HQ: China Website
  • Description: Provider of one-stop atrial fibrillation treatment solutions, offering the NanoAblate pulsed field ablation generator for non-thermal cardiac ablation; PFLine and PFBasket ablation catheters for flexible lesion sets and pulmonary vein isolation; and the DePolar 4D cardiac mapping system with DipperStar and LibStar catheters for real-time, high-resolution mapping.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enchannel company profile →
Relypsa Logo

Relypsa

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development of non-absorbed polymeric drugs for cardiovascular and renal diseases, specializing in iron deficiency, nephrology, and cardio-renal therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Relypsa company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vitatron

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vitatron

2.2 - Growth funds investing in similar companies to Vitatron

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vitatron

4.2 - Public trading comparable groups for Vitatron

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vitatron

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vitatron

What does Vitatron do?

Vitatron is a provider of pacemakers—implanted devices that deliver timed electrical discharges to regulate slow or irregular heart rhythms—and the Vitatron 2090 Programmer, used to program and support advanced Vitatron cardiac devices to meet patient-specific needs.

Who are Vitatron's competitors?

Vitatron's competitors and similar companies include CardioInsight, Portola Pharmaceuticals, CV Therapeutics, Enchannel, and Relypsa.

Where is Vitatron headquartered?

Vitatron is headquartered in The Netherlands.

How many employees does Vitatron have?

Vitatron has 1,000 employees 🔒.

When was Vitatron founded?

Vitatron was founded in 2010 🔒.

What sector and industry vertical is Vitatron in?

Vitatron is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vitatron

Who are the top strategic acquirers in Vitatron's sector and industry

Top strategic M&A buyers and acquirers in Vitatron's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vitatron?

Top strategic M&A buyers groups and sectors for Vitatron include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vitatron's sector and industry vertical

Which are the top PE firms investing in Vitatron's sector and industry vertical?

Top PE firms investing in Vitatron's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vitatron's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vitatron's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vitatron's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vitatron include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vitatron's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vitatron?

The key public trading comparables and valuation benchmarks for Vitatron include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vitatron for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vitatron with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vitatron's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vitatron with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vitatron's' sector and industry vertical?

Access recent funding rounds and capital raises in Vitatron's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vitatron